Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Cancer Research|September 17, 2025
The Microbial Bile Acid Metabolite 3-Oxo-LCA Inhibits Colorectal Cancer ProgressionFei Sun, Ke Wang, Xingchen Dong, et al.
Scientific Reports|March 26, 2022
Impact of baseline culture conditions of cancer organoids when determining therapeutic response and tumor heterogeneityRebecca A DeStefanis, Jeremy D Kratz, Autumn M Olson, et al.
Cancers|September 14, 2024
Carboplatin and Paclitaxel Chemoradiation for Localized Anal Cancer in Patients Not Eligible for Mitomycin and 5-FluorouracilAlyssa K DeZeeuw, Michael F Bassetti, Evie H Carchman, et al.
Molecular Cancer Research : MCR|February 11, 2017
Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA MutationsTyler M Foley, Susan N Payne, Cheri A Pasch, et al.
Plos One|October 7, 2014
Phospholipid ether analogs for the detection of colorectal tumorsDustin A Deming, Molly E Maher, Alyssa A Leystra, et al.
Investigational New Drugs|October 12, 2013
A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumorsDustin A Deming, Jacob Ninan, Howard H Bailey, et al.
Medical Oncology (Northwood, London, England)|September 28, 2021
Live cell molecular analysis of primary prostate cancer organoids identifies persistent androgen receptor signalingErika Heninger, David Kosoff, Tamara S Rodems, et al.
British Journal of Cancer|December 12, 2018
A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancerVera Gorbunova, J Thaddeus Beck, Ralf-Dieter Hofheinz, et al.
British Journal of Cancer|July 28, 2019
Correction: A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancerVera Gorbunova, J Thaddeus Beck, Ralf-Dieter Hofheinz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 30, 2017
Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal CancerChelsea Hope, Philip B Emmerich, Athanasios Papadas, et al.
Pageof 8